These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 94184)

  • 1. Prevalence of hepatitis B virus and primary hepatocellular carcinoma in Asia.
    Obata H; Nishioka K
    Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):621-6. PubMed ID: 94184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
    Prince AM; Vnek J
    Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
    [No Abstract]   [Full Text] [Related]  

  • 3. [Seroconversion of HBs antigen to anti-HBs].
    Ohkoshi S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():88-92. PubMed ID: 15453293
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
    Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
    Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer.
    Maupas P; Coursaget P; Goudeau A; Drucker J; Sankale M; Linhard J; Diebolt G
    Ann Microbiol (Paris); 1977; 128(2):245-53. PubMed ID: 71006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 9. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B virus infection and hepatocellular carcinoma: indication for a possible causal connection even in non-endemic Switzerland].
    Pirovino M; Heer M; Altorfer J; Akovbiantz A; Grob P; Schmid M
    Schweiz Med Wochenschr; 1983 Jun; 113(22):824-6. PubMed ID: 6192495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathophysiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma.
    Shafritz DA; Hadziyannis SJ
    Monogr Pathol; 1987; (28):136-52. PubMed ID: 3023975
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
    Lin X; Qian GS; Lu PX; Wu L; Wen YM
    J Med Virol; 2001 Jul; 64(3):299-304. PubMed ID: 11424118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The vaccine for hepatitis B virus. Definition of criteria for its use].
    Sturm JA
    Rev Paul Med; 1985; 103(1):23-31. PubMed ID: 2994199
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 19. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
    Tang YH
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
    Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
    West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.